{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:36:51Z","timestamp":1694637411414},"reference-count":436,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/wco.0b013e3283313b14","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T07:15:29Z","timestamp":1252998929000},"page":"554-561","source":"Crossref","is-referenced-by-count":1,"title":["Current World Literature"],"prefix":"10.1097","volume":"22","member":"276","reference":[{"key":"-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.expneurol.2008.01.010","article-title":"Mitochondrial fusion and function in Charcot-Marie-Tooth type 2A patient fibroblasts with mitofusin 2 mutations.","volume":"211","author":"Amiott","year":"2008","journal-title":"Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1469-1809.2007.00412.x","article-title":"Charcot-Marie-Tooth disease: a clinico-genetic confrontation.","volume":"72","author":"Barisic","year":"2008","journal-title":"Ann Hum Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000304048.94023.73","article-title":"Late-onset hereditary axonal neuropathies.","volume":"71","author":"Bennett","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00415-008-0847-1","article-title":"Cerebral involvement in axonal Charcot-Marie-Tooth neuropathy caused by mitofusin2 mutations.","volume":"255","author":"Brockmann","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(09)70108-5","article-title":"Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.","volume":"8","author":"Burns","year":"2009","journal-title":"Lancet Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mus.21140","article-title":"Evolution of foot and ankle manifestations in children with CMT1A.","volume":"39","author":"Burns","year":"2009","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11940-008-0011-3","article-title":"Charcot-Marie-Tooth disease [Review].","volume":"10","author":"Carter","year":"2008","journal-title":"Current Treatment Options in Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/bpo.0b013e318070cbe8","article-title":"The role of the dynamic pedobarograph in assessing treatment of cavovarus feet in children with Charcot-Marie-Tooth disease.","volume":"27","author":"Chan","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajhg.2008.12.010","article-title":"Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.","volume":"84","author":"Chow","year":"2009","journal-title":"Am J Hum Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.nmd.2008.05.012","article-title":"Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A.","volume":"18","author":"Chung","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nature07534","article-title":"Mitofusin 2 tethers endoplasmic reticulum to mitochondria.","volume":"456","author":"de Brito","year":"2008","journal-title":"Nature"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/ddm314","article-title":"Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A.","volume":"17","author":"Detmer","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/brain\/awn029","article-title":"Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study.","volume":"131","author":"Dierick","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/jnnp.2007.137679","article-title":"Increased prevalence of obstructive sleep apnoea in patients with Charcot-Marie-Tooth disease: a case control study.","volume":"79","author":"Dziewas","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1212\/01.wnl.0000345373.58618.b6","article-title":"Further evidence that mutations in FGD4\/frabin cause Charcot-Marie-Tooth disease type 4H.","volume":"72","author":"Fabrizi","year":"2009","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1212\/01.wnl.0000335150.23712.3d","article-title":"Hereditary motor neuropathy and heat shock proteins A shocking transformation.","volume":"71","author":"Gooch","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/hmg\/ddn083","article-title":"Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations.","volume":"17","author":"Grandis","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2008.07.001","article-title":"Experimental therapeutics in hereditary neuropathies: the past, the present, and the future.","volume":"5","author":"Herrmann","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2008.07.001","article-title":"Experimental therapeutics in hereditary neuropathies: The past, the present, and the future [Review].","volume":"5","author":"Herrmann","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nmd.2009.01.006","article-title":"The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy.","volume":"19","author":"Houlden","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.wnl.0000319696.14225.67","article-title":"Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN\/CMT type.","volume":"71","author":"Houlden","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/01.wnl.0000319696.14225.67","article-title":"Mutations in the HSP27 (HSPB1) gene cause dominant, recessive, and sporadic distal HMN\/CMT type 2.","volume":"71","author":"Houlden","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2008-1062264","article-title":"Charcot-Marie-Tooth neuropathies: diagnosis and management.","volume":"28","author":"Jani-Acsadi","year":"2008","journal-title":"Semin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/brain\/awp113","article-title":"PMP22 expression in dermal nerve myelin from patients with CMT1A.","volume":"132","author":"Katona","year":"2009","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nbd.2009.01.002","article-title":"Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease.","volume":"34","author":"Madorsky","year":"2009","journal-title":"Neurobiol Dis"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1469-8749.2008.02066.x","article-title":"Current methodological issues in the study of children with inherited neuromuscular disorders [Review].","volume":"50","author":"Mercuri","year":"2008","journal-title":"Dev Med Child Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2008.06.027","article-title":"Hereditary motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough.","volume":"273","author":"Miura","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1212\/01.wnl.0000311275.89032.22","article-title":"Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations.","volume":"70","author":"Nicholson","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/j.1600-0854.2008.00754.x","article-title":"Endosomal phosphoinositides and human diseases.","volume":"9","author":"Nicot","year":"2008","journal-title":"Traffic"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S1474-4422(09)70110-3","article-title":"Diagnosis, natural history, and management of Charcot-Marie-Tooth disease.","volume":"8","author":"Pareyson","year":"2009","journal-title":"Lancet Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.nmd.2008.03.003","article-title":"Candidate screening of the bovine and feline spinal muscular atrophy genes reveals no evidence for involvement in human motor neuron disorders.","volume":"18","author":"Parkinson","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuron.2007.12.021","article-title":"Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice.","volume":"57","author":"Pennuto","year":"2008","journal-title":"Neuron"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nbd.2008.06.015","article-title":"Pharmacological induction of the heat shock response improves myelination in a neuropathic model.","volume":"32","author":"Rangaraju","year":"2008","journal-title":"Neurobiol Dis"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1073\/pnas.0800742105","article-title":"Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot-Marie-Tooth 4B2-like peripheral neuropathy in mice.","volume":"105","author":"Robinson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/awn228","article-title":"Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.","volume":"131","author":"Sevilla","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1529-8027.2008.00196.x","article-title":"Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.","volume":"13","author":"Sheth","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/01.wnl.0000297553.36441.ce","article-title":"Neuropathy progression in Charcot-Marie-Tooth disease type 1A.","volume":"70","author":"Shy","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nmd.2007.09.006","article-title":"Reliability of clinical outcome measures in Charcot-Marie-Tooth disease.","volume":"18","author":"Solari","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ejhg.2009.31","article-title":"Charcot-Marie-Tooth disease.","volume":"17","author":"Szigeti","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2169\/internalmedicine.47.1186","article-title":"Recurrent Takotsubo Cardiomyopathy within a Short Span of Time in a Patient with Hereditary Motor and Sensory Neuropathy.","volume":"47","author":"Uechi","year":"2008","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/NEN.0b013e31818b6cbc","article-title":"Histopathological Findings in Hereditary Motor and Sensory Neuropathy of Axonal Type With Onset in Early Childhood Associated With Mitofusin 2 Mutations.","volume":"67","author":"Vallat","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000327643.05073.eb","article-title":"Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.","volume":"71","author":"Videler","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/01.wnl.0000327643.05073.eb","article-title":"Motor axon loss is associated with hand dysfunction in Charcot-Marie-Tooth disease 1a.","volume":"71","author":"Videler","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1529-8027.2008.00182.x","article-title":"Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A.","volume":"13","author":"Yiu","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","first-page":"44","article-title":"Central motor and sensory pathway involvement in an X-linked Charcot-Marie-Tooth family.","volume":"108","author":"Zambelis","year":"2008","journal-title":"Acta Neurol Belg"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/brain\/awn114","article-title":"Mutation of FIG4 causes a rapidly progressive, asymmetric neuronal degeneration.","volume":"131","author":"Zhang","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1212\/01.wnl.0000304048.94023.73","article-title":"Late-onset hereditary axonal neuropathies.","volume":"71","author":"Bennett","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/bpo.0b013e318070cbe8","article-title":"The role of the dynamic pedobarograph in assessing treatment of cavovarus feet in children with Charcot-Marie-Tooth disease.","volume":"27","author":"Chan","year":"2007","journal-title":"J Pediatr Orthop"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.nurt.2008.07.001","article-title":"Experimental therapeutics in hereditary neuropathies: The past, the present, and the future [Review].","volume":"5","author":"Herrmann","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2008.06.027","article-title":"Hereditary motor and sensory neuropathy with proximal dominancy in the lower extremities, urinary disturbance, and paroxysmal dry cough.","volume":"273","author":"Miura","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","first-page":"2496","article-title":"Mutations in the nervous system-specific HSN2 exon of WNK1 cause hereditary sensory neuropathy type II.","volume":"118","author":"Shekarabi","year":"2008","journal-title":"J Clin Invest"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-007-0804-x","article-title":"A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis.","volume":"27","author":"Agarwal","year":"2008","journal-title":"Clin Rheumatol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.clinbiomech.2007.11.015","article-title":"The effect of diabetic neuropathy and previous foot ulceration in EMG and ground reaction forces during gait.","volume":"23","author":"Akashi","year":"2008","journal-title":"Clin Biomech"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2169\/internalmedicine.47.0901","article-title":"Comparison of Diabetic Neuropathy Symptom score and medial plantar sensory nerve conduction studies in diabetic patients showing normal routine nerve conduction studies.","volume":"47","author":"An","year":"2008","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.clinph.2008.07.005","article-title":"Effects of age on excitability properties in human motor axons.","volume":"119","author":"Bae","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ejpain.2008.01.012","article-title":"Evidence of neuroaxonal degeneration in myofascial pain syndrome: A study of neuromuscular jitter by axonal microstimulation.","volume":"12","author":"Chang","year":"2008","journal-title":"Eur J Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/brain\/awn093","article-title":"The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology.","volume":"131","author":"Devigili","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000336370.51010.a1","article-title":"Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of laboratory and genetic testing (an evidence-based review) Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation [Review].","volume":"72","author":"England","year":"2009","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neucli.2008.02.004","article-title":"Acute motor conduction block neuropathy pattern occurring in the course of an acute inflammatory demyelinating polyradiculoneuropathy.","volume":"38","author":"Fernandez-Torre","year":"2008","journal-title":"Neurophysiol Clin-Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.clinph.2008.08.026","article-title":"Diagnostic value of the electromyography of the extraocular muscles.","volume":"119","author":"Galldiks","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/s00415-008-0794-x","article-title":"Axonal function in a family with episodic ataxia type 2 due to a novel mutation.","volume":"255","author":"Krishnan","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/PHM.0b013e31816de327","article-title":"Amplitude ratio of ulnar sensory nerve action potentials in segmental conduction study - Reference values in healthy subjects and diagnostic usefulness in patients with ulnar neuropathy at the elbow.","volume":"87","author":"Kwon","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.21163","article-title":"SENSORY LOSS IN MULTIFOCAL MOTOR NEUROPATHY: A CLINICAL AND ELECTROPHYSIOLOGICAL STUDY.","volume":"39","author":"Lambrecq","year":"2009","journal-title":"Muscle Nerve"},{"key":"-20210206","first-page":"209","article-title":"Acute neuropathy with multiple motor conduction blocks: A variant of Guillain-Barre syndrome or multifocal motor neuropathy with conduction blocks with acute onset Neurophysiol Clin-Clin N","volume":"38","author":"Lefaucheur","year":"2008","journal-title":"europhysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mus.21055","article-title":"American Association of Neuromuscular Electrodiagnostic Medicine evidenced-based review: Use of surface electromyography in the diagnosis and study of neuromuscular disorders.","volume":"38","author":"Meekins","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/brain\/awn332","article-title":"Motor axon excitability during Wallerian degeneration.","volume":"132","author":"Moldovan","year":"2009","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neucli.2008.05.002","article-title":"Ultrasonography in ulnar neuropathy at the elbow: Relationships to clinical and electrophysiological findings.","volume":"38","author":"Mondelli","year":"2008","journal-title":"Neurophysiol Clin-Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/mus.21085","article-title":"Muscle ultrasound: A grown-up technique for children with neuromuscular disorders.","volume":"38","author":"Pillen","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0317167100008568","article-title":"Motor unit number estimation in neuromuscular disease [Review].","volume":"35","author":"Rashidipour","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/mus.20999","article-title":"Chronic sensorimotor polyradiculopathy with antibodies to P2: An electrophysiological and immunoproteomic analysis.","volume":"38","author":"Rojas-Garcia","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.clinph.2008.01.022","article-title":"Changes in excitability properties associated with axonal regeneration in human neuropathy and mouse Wallerian degeneration.","volume":"119","author":"Sawai","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1468-1331.2008.02227.x","article-title":"Near-nerve needle sensory and medial plantar nerve conduction studies in patients with small-fiber sensory neuropathy.","volume":"15","author":"Uluc","year":"2008","journal-title":"Eur J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/mus.21078","article-title":"Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy.","volume":"38","author":"Yiannikas","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S1474-4422(08)70228-X","article-title":"NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.","volume":"7","author":"Backonja","year":"2008","journal-title":"Lancet Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ejpain.2007.12.004","article-title":"Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.","volume":"12","author":"Baron","year":"2008","journal-title":"Eur J Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdiacomp.2007.08.002","article-title":"Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy.","volume":"23","author":"de Vos","year":"2009","journal-title":"J Diabetes Complications"},{"key":"-20210206","first-page":"389","article-title":"Pregabalin as a treatment for painful diabetic peripheral neuropathy: A meta-analysis.","volume":"33","author":"Hurley","year":"2008","journal-title":"Reg Anesth Pain Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jdiacomp.2007.03.010","article-title":"The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus.","volume":"22","author":"Kadiroglu","year":"2008","journal-title":"J Diabetes Complications"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AJP.0b013e31818a744d","article-title":"Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial.","volume":"25","author":"Norrbrink","year":"2009","journal-title":"Clin J Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2165\/0019053-200826120-00007","article-title":"A Cost-Utility Comparison of Four First-Line Medications in Painful Diabetic Neuropathy.","volume":"26","author":"OConnor","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pain.2008.04.012","article-title":"Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial.","volume":"139","author":"Otto","year":"2008","journal-title":"Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1399-6576.2007.01578.x","article-title":"Antinociceptive efficacy of levetiracetam in a mice model for painful diabetic neuropathy.","volume":"52","author":"Ozcan","year":"2008","journal-title":"Acta Anaesthesiol Scand"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ana.21427","article-title":"Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.","volume":"64","author":"Ranoux","year":"2008","journal-title":"Ann Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1517\/14656560802498149","article-title":"Management of painful diabetic neuropathy [Review].","volume":"9","author":"Tavakoli","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11916-008-0034-1","article-title":"Pathophysiology and treatment of painful diabetic neuropathy [Review].","volume":"12","author":"Tavakoli","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes.","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1468-1331.2008.02206.x","article-title":"Effect of levetiracetam on the postmastectomy pain syndrome.","volume":"15","author":"Vilholm","year":"2008","journal-title":"Eur J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/AJP.0b013e318196d2b6","article-title":"742 Study Group. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.","volume":"25","author":"Wymer","year":"2009","journal-title":"Clin J Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/01.wnl.0000345968.05959.cf","article-title":"Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.","volume":"72","author":"Yuan","year":"2009","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature.","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature [Review].","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000151540","article-title":"Vincristine-induced neuropathy in the rat is not modified by drug-drug interactions with the P-glycoprotein inhibitor verapamil.","volume":"54","author":"Balayssac","year":"2008","journal-title":"Chemotherapy"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00280-008-0689-7","article-title":"Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.","volume":"62","author":"Callizot","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1529-8027.2008.00193.x","article-title":"Characteristics of bortezomib- and thalidomide-induced peripheral neuropathy.","volume":"13","author":"Chaudhry","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1017\/S0265021508004717","article-title":"The neuromuscular effects of 0.6 mg kg(-1) rocuronium in elderly and young adults with or without renal failure.","volume":"25","author":"Kocabas","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"-20210206","first-page":"671","article-title":"Axonal neuropathy with prolonged sulphasalazine use.","volume":"26","author":"Liedorp","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor--blocker therapy.","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11916-008-0030-5","article-title":"Chemotherapy-induced peripheral neuropathy [Review].","volume":"12","author":"Malik","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0404.2008.00996.x","article-title":"Predisposing factors for critical illness polyneuromyopathy in a multidisciplinary intensive care unit.","volume":"118","author":"Nanas","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2174\/092986708786848569","article-title":"Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies.","volume":"15","author":"Park","year":"2008","journal-title":"Curr Med Chem"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/pbc.21786","article-title":"Vincristine Induced Peripheral Neuropathy Potentiated by Voriconazole in a Patient With Previously Undiagnosed CMT1X.","volume":"52","author":"Porter","year":"2009","journal-title":"Pediatric Blood Cancer"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy.","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders.","volume":"207","author":"Stubgen","year":"2009","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.neuro.2008.05.003","article-title":"Vincristine-induced fatal neuropathy in non-Hodgkins lymphoma.","volume":"29","author":"Tarlaci","year":"2008","journal-title":"Neurotoxicology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.pain.2008.09.006","article-title":"Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat.","volume":"140","author":"Thibault","year":"2008","journal-title":"Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1468-1293.2008.00658.x","article-title":"Acetyl-L-carnitine and nucleoside reverse transcriptase inhibitor-associated neuropathy in HIV infection.","volume":"10","author":"Valcour","year":"2009","journal-title":"HIV Medicine"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.surneu.2007.01.060","article-title":"Cranial neuropathies after intracranial Photofrin-photodynamic therapy for malignant supratentorial gliomas - a report on 3 cases.","volume":"70","author":"Varma","year":"2008","journal-title":"Surg Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1529-8027.2008.00156.x","article-title":"Chemotherapy-induced neuropathy.","volume":"13","author":"Windebank","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.","volume":"44","author":"Wolf","year":"2008","journal-title":"Eur J Cancer"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejca.2008.04.018","article-title":"Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies [Review].","volume":"44","author":"Wolf","year":"2008","journal-title":"Eur J Cancer"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1182\/blood-2007-12-126979","article-title":"Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome.","volume":"112","author":"Abe","year":"2008","journal-title":"Blood"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1212\/01.wnl.0000335268.70325.33","article-title":"Long-term effect of rituximab in anti-MAG polyneuropathy.","volume":"71","author":"Benedetti","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ajh.21285","article-title":"A novel report of clg-FISH and cytogenetics in POEMS syndrome.","volume":"83","author":"Bryce","year":"2008","journal-title":"Am J Hematol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2169\/internalmedicine.46.6243","article-title":"Type I Gaucher disease following chemotherapy for light chain multiple myeloma.","volume":"46","author":"Cheung","year":"2007","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncpneuro0942","article-title":"A case of POEMS syndrome treated by autologous hematopoietic stem-cell transplantation.","volume":"4","author":"Creange","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM antimyelin-associated glycoprotein antibody demyelinating neuropathy.","volume":"65","author":"Dalakas","year":"2009","journal-title":"Ann Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1346-8138.2008.00469.x","article-title":"Neutrophilic, urticaria-like erythema associated with immunoglobulin A monoclonal gammopathy of undetermined significance.","volume":"35","author":"Demitsu","year":"2008","journal-title":"J Dermatol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/ajh.21297","article-title":"Acquired iron overload associated with antitransferrin monoclonal immunoglobulin: a case report.","volume":"83","author":"Forni","year":"2008","journal-title":"Am J Hematol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2008-04-149393","article-title":"Differential pattern of CD4(+) and CD8(+) T-cell immunity to MAGE-A1\/A2\/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma.","volume":"112","author":"Goodyear","year":"2008","journal-title":"Blood"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2169\/internalmedicine.46.1882","article-title":"Acquired Fanconi syndrome with osteomalacia secondary to monoclonal gammopathy of undetermined significance.","volume":"46","author":"Hashimoto","year":"2007","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2169\/internalmedicine.46.1713","article-title":"Efficacy of autologous peripheral blood stem cell transplantation in POEMS syndrome with polyneuropathy.","volume":"46","author":"Imai","year":"2007","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ajh.21325","article-title":"Familial myeloma and monoclonal gammopathy: A report of eight African American families.","volume":"84","author":"Jain","year":"2009","journal-title":"Am J Hematol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1358\/dof.2008.033.06.1209527","article-title":"POEMS syndrome [Review].","volume":"33","author":"Laurenti","year":"2008","journal-title":"Drugs of the Future"},{"key":"-20210206","first-page":"264","article-title":"Whats new in paraproteinemic demyelinating neuropathy in 2007-2008 J Peripher Nerv S","volume":"13","author":"Lunn","year":"2008","journal-title":"yst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1188\/08.ONF.763-767","article-title":"Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.","volume":"35","author":"Mullen","year":"2008","journal-title":"Oncology Nursing Forum"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2169\/internalmedicine.48.1679","article-title":"Light Chain Deposition Disease Developing 15 Years Following the Diagnosis of Monoclonal Gammopathy of Undetermined Significance.","volume":"48","author":"Okura","year":"2009","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1600-0560.2007.00884.x","article-title":"The histological and pathogenetic spectrum of cutaneous disease in monoclonal gammopathies [Review].","volume":"35","author":"Rongioletti","year":"2008","journal-title":"J Cutan Pathol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.nurt.2008.08.012","article-title":"Inflammatory demyelinating neuropathies and neuropathies associated with monoclonal gammopathies: Treatment update [Review].","volume":"5","author":"Steck","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.micron.2006.12.005","article-title":"Contribution of electron microscopy to the study of neuropathies associated with an IgG monoclonal paraproteinemia.","volume":"39","author":"Vallat","year":"2008","journal-title":"Micron"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cbi.2008.04.046","article-title":"Cholinesterases in development and disease.","volume":"175","author":"Anglister","year":"2008","journal-title":"Chem Biol Interact"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cbi.2008.04.002","article-title":"Effect of fluoxetine on neuromuscular function in acetylcholinesterase (AChE) knockout mice.","volume":"175","author":"Bertrand","year":"2008","journal-title":"Chem Biol Interact"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/082585970802400406","article-title":"Is There a Role for Palliative Care in Progressive Pediatric Neuromuscular Diseases. The Answer Is Yes!.","volume":"24","author":"Birnkrant","year":"2008","journal-title":"J Palliat Care"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1378\/chest.08-1895","article-title":"Continuous Critical Care and Long-Term Noninvasive Ventilatory Support for Patients With Neuromuscular Disease.","volume":"135","author":"Cheng","year":"2009","journal-title":"Chest"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1017\/S0317167100009240","article-title":"Paraneoplastic neuromuscular disease in lung large cell neuroendocrine carcinoma.","volume":"35","author":"Di Fabio","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2007.08.038","article-title":"Significance of CK-elevation in noncompaction with regard to cardiac and neuromuscular disease.","volume":"130","author":"Finsterer","year":"2008","journal-title":"Int J Cardiol"},{"key":"-20210206","first-page":"8","article-title":"Is it safe to use statins in patients with myasthenia gravis Nat N","volume":"5","author":"Gilhus","year":"2009","journal-title":"eurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12098-008-0132-4","article-title":"Neuromuscular junctional disorders.","volume":"75","author":"Girija","year":"2008","journal-title":"Indian J Pediatr"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of ocular myasthenia in Korea: A retrospective multicenter analysis of 202 patients.","volume":"273","author":"Hong","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2106\/JBJS.G.00184","article-title":"Pulmonary function following early thoracic fusion in non-neuromuscular scoliosis.","volume":"90A","author":"Karol","year":"2008","journal-title":"J Bone Joint Surg-Am Vol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00134-008-1267-5","article-title":"Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis.","volume":"35","author":"Kesler","year":"2009","journal-title":"Intensive Care Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2008.06.026","article-title":"Congenital Myasthenic Syndromes in childhood: Diagnostic and management challenges.","volume":"201","author":"Kinali","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","article-title":"IgG1 antibodies to acetylcholine receptors in seronegative myasthenia gravis.","volume":"131","author":"Leite","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.300.14.1685","article-title":"Mobilizing patients in the intensive care unit - Improving neuromuscular weakness and physical function.","volume":"300","author":"Needham","year":"2008","journal-title":"JAMA"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/mus.21074","article-title":"Statins may aggravate myasthenia gravis.","volume":"38","author":"Oh","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1378\/chest.08-2302","article-title":"Continuous Critical Care and Long-Term Noninvasive Ventilatory Support for Patients With Neuromuscular Disease Response.","volume":"135","author":"Oszancak","year":"2009","journal-title":"Chest"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/NEN.0b013e318180ec64","article-title":"Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves.","volume":"67","author":"Panaite","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09638280701403460","article-title":"Development of a tool to guide referral of patients with neuromuscular disorders to allied health services. Part two.","volume":"30","author":"Pieterse","year":"2008","journal-title":"Disabil Rehabil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/09638280701403437","article-title":"Development of a tool to guide referral of patients with neuromuscular disorders to allied health services. Part one.","volume":"30","author":"Pieterse","year":"2008","journal-title":"Disabil Rehabil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.nurt.2008.07.003","article-title":"Therapeutic strategies in congenital myasthenic syndromes.","volume":"5","author":"Schara","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archneur.65.7.929","article-title":"Predictors of extubation failure in myasthenic crisis.","volume":"65","author":"Seneviratne","year":"2008","journal-title":"Arch Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archneurol.2007.1","article-title":"Noninvasive ventilation in myasthenic crisis.","volume":"65","author":"Seneviratne","year":"2008","journal-title":"Arch Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2008.07.019","article-title":"B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders [Review].","volume":"204","author":"Stugen","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1405.022","article-title":"Antisense treatment for myasthenia gravis. Experience with Monarsen.","volume":"1132","author":"Sussman","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2008.04.040","article-title":"Lambert-Eaton myasthenic syndrome: Search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.","volume":"201","author":"Takamori","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2169\/internalmedicine.47.0682","article-title":"Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia.","volume":"47","author":"Tsuda","year":"2008","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2008.06.031","article-title":"Calcium channels, neuromuscular synaptic transmission and neurological diseases [Review].","volume":"201","author":"Urbano","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1179\/his.2007.30.4.225","article-title":"Insight into the management of neuromuscular diseases and histopathologic techniques.","volume":"30","author":"Villanueva","year":"2007","journal-title":"J Histotechnol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.2009.35","article-title":"Efficacy of 3,4 diaminopyridine and pyridostigmine in the Lambert-Eaton myasthenic syndrome.","volume":"86","author":"Wirtz","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/hmg\/ddn092","article-title":"Lysosomal proliferation and distal degeneration in motor neurons expressing the G59S mutation in the p150(Glued) subunit of dynactin.","volume":"17","author":"Chevalier-Larsen","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1172\/JCI35432","article-title":"Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.","volume":"118","author":"Corti","year":"2008","journal-title":"J Clin Invest"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.1158799","article-title":"Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.","volume":"321","author":"Dimos","year":"2008","journal-title":"Science"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.expneurol.2008.09.019","article-title":"Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease.","volume":"215","author":"Dupuis","year":"2009","journal-title":"Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/hmg\/ddn357","article-title":"Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition.","volume":"18","author":"Hauke","year":"2009","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","article-title":"TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.","volume":"40","author":"Kabashi","year":"2008","journal-title":"Nat Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","article-title":"Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy.","volume":"17","author":"Kariya","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1523\/JNEUROSCI.4434-08.2009","article-title":"Impaired Synaptic Vesicle Release and Immaturity of Neuromuscular Junctions in Spinal Muscular Atrophy Mice.","volume":"29","author":"Kong","year":"2009","journal-title":"J Neurosci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1166066","article-title":"Mutations in the FUS\/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.","volume":"323","author":"Kwiatkowski Jr","year":"2009","journal-title":"Science"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cell.2009.03.006","article-title":"Rethinking ALS: the FUS about TDP-43.","volume":"136","author":"Lagier-Tourenne","year":"2009","journal-title":"Cell"},{"key":"-20210206","first-page":"109","article-title":"ANCA-related vasculitic neuropathy mimicking Motor Neuron Disease.","volume":"108","author":"Luigetti","year":"2008","journal-title":"Acta Neurol Belg"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","article-title":"The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.","volume":"21","author":"Mackenzie","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jns.2007.12.026","article-title":"Madras motor neuron disease (MMND): Clinical description and survival pattern of 116 patients from Southern India seen over 36 years (1971-2007).","volume":"269","author":"Nalini","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17482960801900032","article-title":"A systematic review of antioxidant treatment for amyotrophic lateral sclerosis\/motor neuron disease [Review].","volume":"9","author":"Orrell","year":"2008","journal-title":"Amyotroph Lateral Scler"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.","volume":"86","author":"Tsai","year":"2008","journal-title":"J Mol Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1474-4422(08)70071-1","article-title":"TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.","volume":"7","author":"Van Deerlin","year":"2008","journal-title":"Lancet Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1165942","article-title":"Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6.","volume":"323","author":"Vance","year":"2009","journal-title":"Science"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.21392","article-title":"TDP-43 mutation in familial amyotrophic lateral sclerosis.","volume":"63","author":"Yokoseki","year":"2008","journal-title":"Ann Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10067-007-0804-x","article-title":"A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis.","volume":"27","author":"Agarwal","year":"2008","journal-title":"Clin Rheumatol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/WNF.0b013e3181585b71","article-title":"Tremor associated with chronic inflammatory demyelinating peripheral neuropathy: Treatment with pregabalin [Review].","volume":"31","author":"Alonso-Navarro","year":"2008","journal-title":"Clin Neuropharmacol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1345\/aph.1L179","article-title":"Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.","volume":"42","author":"Amara","year":"2008","journal-title":"Ann Pharmacother"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2008.08.003","article-title":"Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy.","volume":"596","author":"Arora","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1600-0404.2007.00970.x","article-title":"No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy.","volume":"117","author":"Axelson","year":"2008","journal-title":"Acta Neurol Scand"},{"key":"-20210206","first-page":"1434","article-title":"Managing the Patient With Neuromuscular Disease and Respiratory Insufficiency.","volume":"53","author":"Boitano","year":"2008","journal-title":"Respiratory Care"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1007\/s00415-008-0979-3","article-title":"New liquid intravenous immunoglobulin (10 % IVIg) for treatment of multifocal motor neuropathy.","volume":"255","author":"Cats","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14712598.8.5.643","article-title":"Immunotherapy of chronic inflammatory demyelinating polyradiculoneuropathy [Review].","volume":"8","author":"Eftimov","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1345\/aph.1L201","article-title":"Role of Acetyl-L-Carnitine in the Treatment of Diabetic Peripheral Neuropathy.","volume":"42","author":"Evans","year":"2008","journal-title":"Ann Pharmacother"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1464-5491.2008.02490.x","article-title":"Stratified analyses for selecting appropriate target patients with diabetic peripheral neuropathy for long-term treatment with an aldose reductase inhibitor, epalrestat.","volume":"25","author":"Hotta","year":"2008","journal-title":"Diabet Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00415-008-3003-z","article-title":"The role of Wig in autoimmune neuropathies: the latest evidence.","volume":"255","author":"Hughes","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11940-008-0012-2","article-title":"Diagnosis and treatment of multifocal motor neuropathy [Review].","volume":"10","author":"Kaji","year":"2008","journal-title":"Current Treatment Options in Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.clinbiomech.2008.06.004","article-title":"Investigation of standing balance in patients with diabetic neuropathy at different stages of foot complications.","volume":"23","author":"Kanade","year":"2008","journal-title":"Clin Biomech"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/WCO.0b013e32830efc03","article-title":"Intravenous immunoglobulins in the treatment of immune neuropathies.","volume":"21","author":"Kieseier","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1093\/brain\/awn072","article-title":"Complementing the therapeutic armamentarium for Miller Fisher Syndrome and related immune neuropathies.","volume":"131","author":"Lehmann","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/WCO.0b013e32830b0f61","article-title":"Plasma exchange in immune-mediated neuropathies.","volume":"21","author":"Lehmann","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jns.2008.02.022","article-title":"The clinical value of therapeutic plasma exchange in multifocal motor neuropathy.","volume":"271","author":"Lehmann","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/WCO.0b013e3282ff5b8f","article-title":"Use of intravenous immunoglobulin and plasma exchange in neurological disease.","volume":"21","author":"Linker","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nurt.2008.08.010","article-title":"New treatments for neuromuscular disease: Optimism and obstacles.","volume":"5","author":"Lochmuller","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11892-008-0075-1","article-title":"Gene Therapy for the Treatment of Diabetic Neuropathy.","volume":"8","author":"Mata","year":"2008","journal-title":"Curr Diabetes Rep"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/0003319708321100","article-title":"The Effects of Cilostazol on Peripheral Neuropathy in Diabetic Patients With Peripheral Arterial Disease.","volume":"59","author":"ODonnell","year":"2008","journal-title":"Angiology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2230.2008.02744.x","article-title":"Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.","volume":"33","author":"Peter","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncpendmet1019","article-title":"Pregabalin for painful diabetic peripheral neuropathy.","volume":"5","author":"Rogers","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metabol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/WCO.0b013e32830f1e3b","article-title":"How to assess new drugs for neuropathies: advances in trial design and methodology.","volume":"21","author":"van Doorn","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1007\/s11695-008-9539-2","article-title":"Peripheral Neuropathy and Severe Malnutrition following Duodenal Switch.","volume":"18","author":"Aasheim","year":"2008","journal-title":"Obesity Surgery"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00330-008-0940-y","article-title":"Upper extremity peripheral neuropathies: role and impact of MR imaging on patient management.","volume":"18","author":"Andreisek","year":"2008","journal-title":"Eur Radiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/jnnp.2006.109785","article-title":"Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy [Review].","volume":"84","author":"Antoine","year":"2008","journal-title":"Postgrad Med J"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/mus.21042","article-title":"Unilateral diaphragmatic paralysis and segmental motor paresis following herpes zoster.","volume":"38","author":"Bahadir","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/WCO.0b013e32830f226d","article-title":"Neuropathies in the context of malignancies.","volume":"21","author":"Behin","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","first-page":"1434","article-title":"Managing the Patient With Neuromuscular Disease and Respiratory Insufficiency.","volume":"53","author":"Boitano","year":"2008","journal-title":"Respiratory Care"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ncpneuro0920","article-title":"Pitfalls of diagnostic criteria for small fiber neuropathy.","volume":"4","author":"Botez","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.nec.2008.07.001","article-title":"Controversial Entrapment Neuropathies.","volume":"19","author":"Campbell","year":"2008","journal-title":"Neurosurg Clin North Am"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ncl.2008.03.001","article-title":"Critical illness neuromuscular syndromes.","volume":"26","author":"De Jonghe","year":"2008","journal-title":"Neurol Clin"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/micr.20513","article-title":"Reversal of toe clawing in the patient with neuropathy by neurolysis of the distal tibial nerve.","volume":"28","author":"Dellon","year":"2008","journal-title":"Microsurgery"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2522\/ptj.20080020","article-title":"Epidemiology of Diabetes and Diabetes-Related Complications.","volume":"88","author":"Deshpande","year":"2008","journal-title":"Phys Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2036.2008.03707.x","article-title":"Review article: molecular, pathological and therapeutic features of human enteric neuropathies [Review].","volume":"28","author":"Di Nardo","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1177\/0883073808318058","article-title":"Isolated Vitamin E Deficiency Mimicking Distal Hereditary Motor Neuropathy in a 13-Year-Old Boy.","volume":"23","author":"Fusco","year":"2008","journal-title":"J Child Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mus.21115","article-title":"DISCRIMINATING NEUROGENIC FROM MYOPATHIC DISEASE VIA MEASUREMENT OF MUSCLE ANISOTROPY.","volume":"39","author":"Garmirian","year":"2009","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ncl.2008.04.001","article-title":"Diagnosis and management of HIV-associated neuropathy.","volume":"26","author":"Gonzalez-Duarte","year":"2008","journal-title":"Neurol Clin"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awm316","article-title":"Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model.","volume":"131","author":"Halstead","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.diabres.2008.03.019","article-title":"The quality of life and economic burden of neuropathy in diabetic patients in Germany in 2002 - Results from the diabetic microvascular complications (DIMICO) study.","volume":"81","author":"Happich","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jns.2008.07.021","article-title":"Facial onset sensory and motor neuronopathy (FOSMN) syndrome responding to immunotherapies.","volume":"275","author":"Hokonohara","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00134-008-1304-4","article-title":"Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.","volume":"35","author":"Hough","year":"2009","journal-title":"Intensive Care Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/01.wnl.0000335160.72184.7d","article-title":"GM1\/GalNAc-GD1a complex A target for pure motor Guillain-Barre syndrome.","volume":"71","author":"Kaida","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.wnl.0000339483.86094.a5","article-title":"X-linked distal hereditary motor neuropathy maps to the DSMAX locus on chromosome Xq13.1-q21.","volume":"72","author":"Kennerson","year":"2009","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1471-6712.2007.00520.x","article-title":"Hypoventilation does not explain the impaired quality of sleep in postpolio patients ventilated noninvasively vs. invasively.","volume":"22","author":"Klang","year":"2008","journal-title":"Scand J Caring Sciences"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/brain\/awn052","article-title":"Activity-dependent excitability changes suggest Na+\/K+ pump dysfunction in diabetic neuropathy.","volume":"131","author":"Krishnan","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/jjco\/hyn100","article-title":"A Questionnaire Survey of Physicians Perspectives Regarding the Assessment of Chemotherapy-induced Peripheral Neuropathy in Patients with Breast Cancer.","volume":"38","author":"Kuroi","year":"2008","journal-title":"Jpn J Clin Oncol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000165347","article-title":"Brucella: A Cause of Peripheral Neuropathy.","volume":"61","author":"Kutlu","year":"2009","journal-title":"Eur Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1177\/0883073808315617","article-title":"Leucoencephalopathy, Transverse Myelopathy, and Peripheral Neuropathy in Association With Glutamic Acid Decarboxylase-65 (GAD) Antibodies in Children With Cancer.","volume":"23","author":"Ledet","year":"2008","journal-title":"J Child Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1526-4637.2008.00470.x","article-title":"Detection of a Characteristic Painful Neuropathy in Fabry Disease: A Pilot Study.","volume":"9","author":"Maag","year":"2008","journal-title":"Pain Medicine"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nmd.2008.09.001","article-title":"Being the lifeline: The parent experience of caring for a child with neuromuscular disease on home mechanical ventilation.","volume":"18","author":"Mah","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mus.21219","article-title":"Case of acute motor conduction block neuropathy (amcbn).","volume":"39","author":"Manganelli","year":"2009","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/mus.21005","article-title":"Nine-year case history of monofocal motor neuropathy.","volume":"38","author":"Manganelli","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.gaitpost.2008.01.004","article-title":"The reliability of physical performance measures in peripheral neuropathy.","volume":"28","author":"Manor","year":"2008","journal-title":"Gait Posture"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10029-007-0290-8","article-title":"Pathology of ilioinguinal neuropathy produced by mesh entrapment: case report and literature review.","volume":"12","author":"Miller","year":"2008","journal-title":"Hernia"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00383-008-2198-5","article-title":"Critical illness polyneuropathy following childhood appendicitis.","volume":"24","author":"Mullassery","year":"2008","journal-title":"Pediatr Surg Int"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00296-008-0630-8","article-title":"Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment [Review].","volume":"28","author":"Muramatsu","year":"2008","journal-title":"Rheumatol Int"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pediatrneurol.2008.03.014","article-title":"Serologic marker of acute motor axonal neuropathy in childhood.","volume":"39","author":"Nishimoto","year":"2008","journal-title":"Pediatr Neurol"},{"key":"-20210206","first-page":"261","article-title":"Whats new in multifocal motor neuropathy in 2007-2008 J Peripher Nerv S","volume":"13","author":"Nobile-Orazio","year":"2008","journal-title":"yst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pain.2007.11.009","article-title":"Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy.","volume":"138","author":"Obermann","year":"2008","journal-title":"Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00192-008-0683-y","article-title":"Transient obturator neuropathy due to local anesthesia during transobturator sling placement.","volume":"20","author":"Park","year":"2009","journal-title":"Int Urogynecol J"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1136\/pgmj.2007.064915","article-title":"Approach to critical illness polyneuropathy and myopathy [Review].","volume":"84","author":"Pati","year":"2008","journal-title":"Postgrad Med J"},{"key":"-20210206","first-page":"CS89","article-title":"Severe but preventable foot burn injury in diabetic patients with peripheral neuropathy.","volume":"14","author":"Putz","year":"2008","journal-title":"Med Sci Monitor"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/mus.20956","article-title":"Congenital diaphragm weakness without neuromuscular disease.","volume":"38","author":"Renault","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/mus.20999","article-title":"Chronic sensorimotor polyradiculopathy with antibodies to P2: An electrophysiological and immunoproteomic analysis.","volume":"38","author":"Rojas-Garcia","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00415-008-0999-z","article-title":"Sensory loss, pains, motor deficit and axonal regeneration in length-dependent diabetic polyneuropathy.","volume":"255","author":"Said","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/awn228","article-title":"Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.","volume":"131","author":"Sevilla","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/mus.21061","article-title":"Late-onset Tay-Sachs disease: The spectrum of peripheral neuropathy in 30 affected patients.","volume":"38","author":"Shapiro","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MAJ.0b013e31815ae3fc","article-title":"Brucellosis Mimicking Vasculitis in a Patient With Renal Failure and Peripheral Neuropathy.","volume":"336","author":"Shoja","year":"2008","journal-title":"Am J Med Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/hon.845","article-title":"Review of peripheral neuropathy in plasma cell disorders [Review].","volume":"26","author":"Silberman","year":"2008","journal-title":"Hematol Oncol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1529-8027.2008.00180.x","article-title":"The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy.","volume":"13","author":"Singleton","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2008.02.008","article-title":"Motor variant of chronic inflammatory demyelinating polyneuropathy in a child.","volume":"38","author":"Sinno","year":"2008","journal-title":"Pediatr Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/mds.22137","article-title":"Neuropathy as a Potential Complication of Levodopa Use in Parkinsons Disease.","volume":"23","author":"Toth","year":"2008","journal-title":"Mov Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.nec.2008.07.031","article-title":"Whats New in Common Upper Extremity Entrapment Neuropathies.","volume":"19","author":"Toussaint","year":"2008","journal-title":"Neurosurg Clin North Am"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/dmrr.856","article-title":"Neuropathy: mobility and quality of life.","volume":"24","author":"van Schie","year":"2008","journal-title":"Diabetes-Metab Res Rev"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1526-4637.2007.00347.x","article-title":"Painful diabetic neuropathy: Epidemiology, natural history, early diagnosis, and treatment options [Review].","volume":"9","author":"Veves","year":"2008","journal-title":"Pain Medicine"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/mus.21041","article-title":"Childhood multifocal acquired demyelinating sensory and motor neuropathy.","volume":"37","author":"Wakamoto","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4065\/83.11.1226","article-title":"Patterns of Neuropathy and Autonomic Failure in Patients With Amyloidosis.","volume":"83","author":"Wang","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1440-1819.2008.01889.x","article-title":"Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes.","volume":"63","author":"Yoshida","year":"2009","journal-title":"Psychiat Clin Neurosciences"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-5491.2008.02616.x","article-title":"Healthcare charges and utilization associated with diabetic neuropathy: impact of Type 1 diabetes and presence of other diabetes-related complications and comorbidities.","volume":"26","author":"Zhao","year":"2009","journal-title":"Diabet Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/jpet.108.139410","article-title":"Specific Antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.","volume":"326","author":"Bordet","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.mvr.2007.12.002","article-title":"Endoneurial microvascular pathology in feline diabetic neuropathy.","volume":"75","author":"Estrella","year":"2008","journal-title":"Microvasc Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11154-008-9104-2","article-title":"Mechanisms of disease: The oxidative stress theory of diabetic neuropathy [Review].","volume":"9","author":"Figueroa-Romero","year":"2008","journal-title":"Rev Endocrine Metab Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jns.2008.03.002","article-title":"Standing balance and trunk position sense in impaired glucose tolerance (IGT)-related peripheral neuropathy.","volume":"270","author":"Goldberg","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1529-8027.2008.00195.x","article-title":"Inhibition of inducible nitric oxide synthase reduces an acute peripheral motor neuropathy produced by dermal burn injury in mice.","volume":"13","author":"Higashimori","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2522\/ptj.20080079","article-title":"Excessive Adipose Tissue Infiltration in Skeletal Muscle in Individuals With Obesity, Diabetes Mellitus, and Peripheral Neuropathy: Association With Performance and Function.","volume":"88","author":"Hilton","year":"2008","journal-title":"Phys Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2169\/internalmedicine.47.1323","article-title":"Pancytopenia Complicated with Peripheral Neuropathy Due to Copper Deficiency: Clinical Diagnostic Review.","volume":"47","author":"Imataki","year":"2008","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygeno.2007.12.010","article-title":"A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice.","volume":"91","author":"Jiao","year":"2008","journal-title":"Genomics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pain.2008.07.007","article-title":"Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy.","volume":"140","author":"Johnson","year":"2008","journal-title":"Pain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/ejhg.2008.132","article-title":"Axonal neuropathy with unusual pattern of amyotrophy and alacrima associated with a novel AAAS mutation p.Leu430Phe.","volume":"16","author":"Koehler","year":"2008","journal-title":"Eur J Human Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ncpneuro0938","article-title":"Early detection of nerve damage and repair in diabetic neuropathy.","volume":"4","author":"Malik","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1254\/jphs.08071FP","article-title":"Long-term treatment with ranirestat (AS-3201), a potent aldose reductase inhibitor, suppresses diabetic neuropathy and cataract formation in rats.","volume":"107","author":"Matsumoto","year":"2008","journal-title":"Journal of Pharmacological Sciences"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1254\/jphs.08061FP","article-title":"Ranirestat (AS-3201), a potent aldose reductase inhibitor, reduces sorbitol levels and improves motor nerve conduction velocity in streptozotocin-diabetic rats.","volume":"107","author":"Matsumoto","year":"2008","journal-title":"Journal of Pharmacological Sciences"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nmd.2008.05.013","article-title":"Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders.","volume":"18","author":"Peat","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.clinph.2008.08.007","article-title":"Immune-mediated neuropathies in myeloma patients treated with bortezomib.","volume":"119","author":"Ravaglia","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/WCO.0b013e32830b84b7","article-title":"Ganglioside antibodies and neuropathies.","volume":"21","author":"Rinaldi","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nbd.2008.02.013","article-title":"Oxidative injury and neuropathy in diabetes and impaired glucose tolerance.","volume":"30","author":"Russell","year":"2008","journal-title":"Neurobiol Disease"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1529-8027.2008.00196.x","article-title":"Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.","volume":"13","author":"Sheth","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00249-008-0284-1","article-title":"Differences between the channels, currents and mechanisms of conduction slowing\/block and accommodative processes in simulated cases of focal demyelinating neuropathies.","volume":"37","author":"Stephanova","year":"2008","journal-title":"Eur Biophys J Biophys Lett"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11916-008-0029-y","article-title":"Status of immune mediators in painful neuropathies [Review].","volume":"12","author":"Uceyler","year":"2008","journal-title":"Curr Pain Headache Rep"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mus.21057","article-title":"Intranervous immunoglobulin deposits: An underestimated mechanism of neuropathy.","volume":"38","author":"Vallat","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1529-8027.2008.00169.x","article-title":"Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials [Review].","volume":"13","author":"van Nes","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1007\/s00125-008-1136-3","article-title":"Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.","volume":"51","author":"Vareniuk","year":"2008","journal-title":"Diabetologia"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2008.05.028","article-title":"The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre syndrome.","volume":"201","author":"Willison","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1179\/174313208X291694","article-title":"Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy.","volume":"30","author":"Yerdelen","year":"2008","journal-title":"Neurol Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2982.2008.01091.x","article-title":"Characterization of myenteric neuropathy in the jejunum of spontaneously diabetic BB-rats.","volume":"20","author":"Zandecki","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/1073858408316175","article-title":"Neuronal targeting in diabetes mellitus: A story of sensory neurons and motor neurons.","volume":"14","author":"Zochodne","year":"2008","journal-title":"Neuroscientist"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/ajcn\/88.4.950","article-title":"Positive energy balance is associated with accelerated muscle atrophy and increased erythrocyte glutathione turnover during 5 wk of bed rest.","volume":"88","author":"Biolo","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2008.04.007","article-title":"Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients.","volume":"27","author":"Carrero","year":"2008","journal-title":"Clin Nutr"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/mus.21127","article-title":"Immobilization-induced increase in fatigue resistance is not explained by changes in the muscle metaboreflex.","volume":"38","author":"Clark","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1113\/jphysiol.2008.160150","article-title":"A potential role for Akt\/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle.","volume":"586","author":"Crossland","year":"2008","journal-title":"J Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MRR.0b013e3282fc0fa4","article-title":"Muscle hypertrophy in quadriplegics with combined electrical stimulation and body weight support training.","volume":"31","author":"de Abreu","year":"2008","journal-title":"Int J Rehabil Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00421-008-0703-0","article-title":"Effect of 5 weeks horizontal bed rest on human muscle thickness and architecture of weight bearing and non-weight bearing muscles.","volume":"104","author":"de Boer","year":"2008","journal-title":"Eur J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000324623.89105.c4","article-title":"Natural history of SMA IIIb - Muscle strength decreases in a predictable sequence and magnitude.","volume":"71","author":"Deymeer","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1152\/japplphysiol.00021.2008","article-title":"Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging.","volume":"104","author":"Drummond","year":"2008","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1113\/jphysiol.2008.163816","article-title":"Rapamycin administration in humans blocks the contraction-induced increase in skeletal muscle protein synthesis.","volume":"587","author":"Drummond","year":"2009","journal-title":"J Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1152\/japplphysiol.90842.2008","article-title":"Expression of growth-related genes in young and older human skeletal muscle following an acute stimulation of protein synthesis.","volume":"106","author":"Drummond","year":"2009","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1152\/japplphysiol.91331.2008","article-title":"Strength training the free limb attenuates strength loss during unilateral immobilization.","volume":"106","author":"Farthing","year":"2009","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/JSM.0b013e3181845f1c","article-title":"The Aging of Elite Male Athletes: Age-Related Changes in Performance and Skeletal Muscle Structure and Function.","volume":"18","author":"Faulkner","year":"2008","journal-title":"Clin J Sport Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1152\/japplphysiol.90332.2008","article-title":"Muscle fiber size and function in elderly humans: a longitudinal study.","volume":"105","author":"Frontera","year":"2008","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/jor.20577","article-title":"Upregulation of alpha-skeletal muscle actin and myosin heavy polypeptide gene products in degenerating rotator cuff muscles.","volume":"26","author":"Fuchs","year":"2008","journal-title":"J Orthop Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1113\/jphysiol.2008.160333","article-title":"Immobilization induces anabolic resistance in human myofibrillar protein synthesis with low and high dose amino acid infusion.","volume":"586","author":"Glover","year":"2008","journal-title":"J Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"E595","DOI":"10.1152\/ajpendo.90411.2008","article-title":"Disassociation between the effects of amino acids and insulin on signalling, ubiquitin-ligases and protein turnover in human muscle.","volume":"295","author":"Greenhaff","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MCO.0b013e3282fa1810","article-title":"Epigenetic drugs in the treatment of skeletal muscle atrophy [Review].","volume":"11","author":"Guasconi","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1113\/jphysiol.2008.164483","article-title":"Age-related differences in the dose-response relationship of muscle protein synthesis to resistance exercise in young and old men.","volume":"587","author":"Kumar","year":"2009","journal-title":"J Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/rej.2007.0588","article-title":"Human sarcopenia reveals an increase in SOCS-3 and myostatin and a reduced efficiency of Akt phosphorylation.","volume":"11","author":"Leger","year":"2008","journal-title":"Rejuvenation Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","article-title":"Nuclear factor-kappa B signaling in skeletal muscle atrophy [Review].","volume":"86","author":"Li","year":"2008","journal-title":"J Mol Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1517\/14728210802544476","article-title":"Update on emerging drugs for sarcopenia - age-related muscle wasting [Review].","volume":"13","author":"Lynch","year":"2008","journal-title":"Expert Opin Emerg Drugs"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1152\/physrev.00028.2007","article-title":"Role of beta-adrenoceptor signaling in skeletal muscle: Implications for muscle wasting and disease [Review].","volume":"88","author":"Lynch","year":"2008","journal-title":"Physiol Rev"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.10.011","article-title":"The involvement of the ubiquitin proteasome system in human skeletal muscle remodelling and atrophy [Review].","volume":"1782","author":"Murton","year":"2008","journal-title":"Biochim Biophys Acta-Mol Basis Dis"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/jama.300.14.1685","article-title":"Mobilizing patients in the intensive care unit - Improving neuromuscular weakness and physical function.","volume":"300","author":"Needham","year":"2008","journal-title":"JAMA"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1007\/s00415-008-0959-7","article-title":"Computer-aided visualization of muscle weakness distribution.","volume":"255","author":"Pieterse","year":"2008","journal-title":"J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pharmthera.2008.06.003","article-title":"The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting [Review].","volume":"120","author":"Ryall","year":"2008","journal-title":"Pharmacol Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1152\/physiol.00041.2007","article-title":"Signaling in muscle atrophy and hypertrophy [Review].","volume":"23","author":"Sandri","year":"2008","journal-title":"Physiology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11999-008-0565-0","article-title":"Expression of Atrophy mRNA Relates to Tendon Tear Size in Supraspinatus Muscle.","volume":"467","author":"Schmutz","year":"2009","journal-title":"Clin Orthop Related Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/cdd.2008.68","article-title":"Atrophy and programmed cell death of skeletal muscle [Review].","volume":"15","author":"Schwartz","year":"2008","journal-title":"Cell Death Differ"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"e1875","DOI":"10.1371\/journal.pone.0001875","article-title":"Differences in muscle protein synthesis and anabolic signaling in the postabsorptive state and in response to food in 65-80 year old men and women.","volume":"3","author":"Smith","year":"2008","journal-title":"PLoS ONE"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1152\/ajpendo.90226.2008","article-title":"Calpain activity and muscle wasting in sepsis [Review].","volume":"295","author":"Smith","year":"2008","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1152\/japplphysiol.90558.2008","article-title":"Skeletal muscle proteolysis in response to short-term unloading in humans.","volume":"105","author":"Tesch","year":"2008","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1152\/japplphysiol.90558.2008","article-title":"Skeletal muscle proteolysis in response to short-term unloading in humans.","volume":"105","author":"Tesch","year":"2008","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/japplphysiol.91578.2008","article-title":"Exercise in space: human skeletal muscle after 6 months aboard the International Space Station.","volume":"106","author":"Trappe","year":"2009","journal-title":"J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1113\/jphysiol.2008.153916","article-title":"Differential effects of resistance and endurance exercise in the fed state on signalling molecule phosphorylation and protein synthesis in human muscle.","volume":"586","author":"Wilkinson","year":"2008","journal-title":"J Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00421-008-0899-z","article-title":"20-Hz whole body vibration training fails to counteract the decrease in leg muscle volume caused by 14 days of 6A degrees head down tilt bed rest.","volume":"105","author":"Zange","year":"2009","journal-title":"Eur J Appl Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1021\/jm800001n","article-title":"(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1H-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor with reduced myotoxicity potential.","volume":"51","author":"Ahmad","year":"2008","journal-title":"J Med Chem"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/cvr\/cvn131","article-title":"Steroid treatment causes deterioration of myocardial function in the delta-sarcoglycan-deficient mouse model for dilated cardiomyopathy.","volume":"79","author":"Bauer","year":"2008","journal-title":"Cardiovasc Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00401-008-0348-4","article-title":"TNF alpha receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice.","volume":"115","author":"De Paepe","year":"2008","journal-title":"Acta Neuropathol (Berl)"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12192-008-0062-0","article-title":"Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappa B activation and expression.","volume":"13","author":"Frier","year":"2008","journal-title":"Cell Stress Chaperones"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jns.2007.10.026","article-title":"Effects of short-term zidovudine exposure on mitochondrial DNA content and succinate dehydrogenase activity of rat skeletal muscle cells.","volume":"268","author":"Kiyomoto","year":"2008","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/WCO.0b013e32830e2774","article-title":"Drug-induced myopathies.","volume":"21","author":"Klopstock","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2125.2008.03224.x","article-title":"Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products.","volume":"66","author":"Lapi","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/15563650802139948","article-title":"A novel neuromuscular syndrome associated with clenbuterol-tainted heroin.","volume":"46","author":"Manini","year":"2008","journal-title":"Clin Toxicol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pds.1535","article-title":"Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis.","volume":"17","author":"McAdams","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMe0805136","article-title":"Pharmacogenomics and drug toxicity.","volume":"359","author":"Nakamura","year":"2008","journal-title":"N Engl J Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jb\/mvn126","article-title":"Effects of Dimethyl Sulphoxide and Dexamethasone on mRNA Expression of Myogenesis- and Muscle Proteolytic System-related Genes in Mouse Myoblastic C2C12 Cells.","volume":"144","author":"Nishimura","year":"2008","journal-title":"J Biochem"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SEARCH Collaborative. SLCO1B1 variants and statin-induced myopathy: a genomewide study.","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"-20210206","first-page":"2805","article-title":"HIV-1 transgenic expression in mice induces selective atrophy of fast-glycolytic skeletal muscle fibers.","volume":"2797-","author":"Serrano","year":"2008","journal-title":"Front Biosci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2169\/internalmedicine.47.0682","article-title":"Thyrotoxic myopathy mimicking myasthenic syndrome associated with thymic hyperplasia.","volume":"47","author":"Tsuda","year":"2008","journal-title":"Intern Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1073\/pnas.0800546105","article-title":"TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression.","volume":"105","author":"Ayala","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"b2680","DOI":"10.1136\/bmj.b2680","article-title":"How citation distortions create unfounded authority: analysis of a citation network.","volume":"339","author":"Greenberg","year":"2009","journal-title":"Br Med J"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1093\/brain\/awn163","article-title":"Comment on Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle.","volume":"132","author":"Greenberg","year":"2009","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2353\/ajpath.2008.071009","article-title":"L-arginine decreases inflammation and modulates the nuclear factor-kappa B\/matrix metalloproteinase cascade in mdx muscle fibers.","volume":"172","author":"Hnia","year":"2008","journal-title":"Am J Pathol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jocn.2007.03.006","article-title":"Two-dimensional gel electrophoresis in inclusion body myositis.","volume":"15","author":"Hutchinson","year":"2008","journal-title":"J Clin Neurosci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis.","volume":"60","author":"Lopez De Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/NEN.0b013e3181996d8f","article-title":"TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.","volume":"68","author":"Olive","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.21386","article-title":"Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.","volume":"40","author":"Salajegheh","year":"2009","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1093\/brain\/awn164","article-title":"Inflammation interrelates to APP in sIBM: IL-1beta induces accumulation of beta-amyloid.","volume":"132","author":"Schmidt","year":"2009","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2008.12.024","article-title":"CCR7 myeloid dendritic cells together with CCR7 T cells and CCR7 macrophages invade CCL19 nonnecrotic muscle fibers in inclusion body myositis.","volume":"279","author":"Tateyama","year":"2009","journal-title":"J Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/jnnp.2007.131334","article-title":"TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.","volume":"79","author":"Weihl","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nurt.2008.08.008","article-title":"Idiopathic inflammatory myopathies: current and future therapeutic options.","volume":"5","author":"Wiendl","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/0883073807307974","article-title":"Dosage effect of a dominant CLCN1 mutation: a novel syndrome.","volume":"23","author":"Bernard","year":"2008","journal-title":"J Child Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.nurt.2008.09.001","article-title":"Treatment of neuromuscular channelopathies: current concepts and future prospects.","volume":"5","author":"Cleland","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.nurt.2008.09.001","article-title":"Treatment of neuromuscular channelopathies: Current concepts and future prospects [Review].","volume":"5","author":"Cleland","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nmd.2008.07.004","article-title":"Nongenomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita.","volume":"18","author":"Fialho","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"19980","DOI":"10.1073\/pnas.0810562105","article-title":"Depolarization-activated gating pore current conducted by mutant sodium channels in potassium-sensitive normokalemic periodic paralysis.","volume":"105","author":"Sokolov","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1085\/jgp.200709755","article-title":"A Na channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore.","volume":"130","author":"Struyk","year":"2007","journal-title":"J Gen Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1085\/jgp.200809967","article-title":"Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.","volume":"132","author":"Struyk","year":"2008","journal-title":"J Gen Physiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1093\/hmg\/ddn213","article-title":"Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotonia.","volume":"17","author":"Stum","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2008.04.040","article-title":"Lambert-Eaton myasthenic syndrome: Search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.","volume":"201","author":"Takamori","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jneuroim.2008.05.025","article-title":"The Lambert-Eaton myasthenic syndrome 1988-2008: A clinical picture in 97 patients.","volume":"201","author":"Titulaer","year":"2008","journal-title":"J Neuroimmunol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.2008.162396","article-title":"Redefining the clinical phenotypes of nondystrophic myotonic syndromes.","volume":"80","author":"Trip","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ejhg.2008.39","article-title":"In tandem analysis of CLCN1 and SCN4A greatly enhances mutation detection in families with non-dystrophic myotonia.","volume":"16","author":"Trip","year":"2008","journal-title":"Eur J Human Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00424-008-0528-z","article-title":"Expression of the muscular dystrophy-associated caveolin-3(P104L) mutant in adult mouse skeletal muscle specifically alters the Ca2+ channel function of the dihydropyridine receptor.","volume":"457","author":"Weiss","year":"2008","journal-title":"Pflugers Arch"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/PHM.0b013e3181583ddc","article-title":"Use of weekly alendronate to treat osteoporosis in boys with muscular dystrophy.","volume":"87","author":"Apkon","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"key":"-20210206","first-page":"527","article-title":"Clinical approaches in the treatment of Duchenne muscular dystrophy (DMD) using oligonucleotides.","volume":"517-","author":"Bertoni","year":"2008","journal-title":"Front Biosci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMcibr0805708","article-title":"Cell therapies for muscular dystrophy.","volume":"359","author":"Blau","year":"2008","journal-title":"N Engl J Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1089\/hum.2008.058","article-title":"Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice.","volume":"19","author":"Bostick","year":"2008","journal-title":"Hum Gene Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11940-008-0010-4","article-title":"Treatment options for Duchenne muscular dystrophy [Review].","volume":"10","author":"Ciafaloni","year":"2008","journal-title":"Current Treatment Options in Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.nmd.2008.09.003","article-title":"Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy Response.","volume":"18","author":"Cripe","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1358\/dof.2008.033.09.1252090","article-title":"Ataluren. Nonsense mutation suppressor, Treatment of cystic fibrosis, Treatment of muscular dystrophy.","volume":"33","author":"Davies","year":"2008","journal-title":"Drugs of the Future"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1089\/hum.2008.012","article-title":"Long-term benefit of adeno-associated virus\/antisense-mediated exon skipping in dystrophic mice.","volume":"19","author":"Denti","year":"2008","journal-title":"Hum Gene Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s00018-008-7574-8","article-title":"Two-tiered hypotheses for Duchenne muscular dystrophy [Review].","volume":"65","author":"Grounds","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.1212\/01.wnl.0000324282.19778.b5","article-title":"Gene therapy and muscular dystrophies.","volume":"71","author":"Karceski","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/hmg\/ddn151","article-title":"Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.","volume":"17","author":"Kimura","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/hum.2008.009","article-title":"Protein trans-splicing as a means for viral vector-mediated in vivo gene therapy.","volume":"19","author":"Li","year":"2008","journal-title":"Hum Gene Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/adc.2007.118141","article-title":"Update on the management of Duchenne muscular dystrophy [Review].","volume":"93","author":"Manzur","year":"2008","journal-title":"Arch Dis Child"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nmd.2008.03.002","article-title":"Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy.","volume":"18","author":"Markham","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejpn.2008.02.006","article-title":"Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: A magnetic resonance imaging study.","volume":"13","author":"Mavrogeni","year":"2009","journal-title":"European Journal of Paediatric Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1517\/14712598.8.8.1051","article-title":"Combining stem cells and exon skipping strategy to treat muscular dystrophy [Review].","volume":"8","author":"Meregalli","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03256275","article-title":"Molecular-targeted therapy for Duchenne muscular dystrophy - Progress and potential.","volume":"12","author":"Scime","year":"2008","journal-title":"Mol Diagn Ther"},{"key":"-20210206","first-page":"401","article-title":"Are corticosteroids effective in Duchenne muscular dystrophy Indian P","volume":"45","author":"Shah","year":"2008","journal-title":"ediatr"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/hum.2007.129","article-title":"Functionalized PEG-PEI copolymers complexed to exon-skipping oligonucleotides improve dystrophin expression in mdx mice.","volume":"19","author":"Sirsi","year":"2008","journal-title":"Hum Gene Ther"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/brain\/awn189","article-title":"Endurance training improves fitness and strength in patients with Becker muscular dystrophy.","volume":"131","author":"Sveen","year":"2008","journal-title":"Brain"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1074\/jbc.M709410200","article-title":"Generation and characterization of transgenic mice with the full-length human DMD gene.","volume":"283","author":"t Hoen","year":"2008","journal-title":"J Biol Chem"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.nmd.2008.09.002","article-title":"Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.","volume":"18","author":"van Baalen","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nurt.2008.08.013","article-title":"Approaching a new age in Duchenne muscular dystrophy treatment [Review].","volume":"5","author":"Wagner","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1093\/hmg\/ddn293","article-title":"Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function.","volume":"17","author":"Yin","year":"2008","journal-title":"Hum Mol Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/archneurol.2008.540","article-title":"A Renaissance for Antisense Oligonucleotide Drugs in Neurology Exon Skipping Breaks New Ground [Review].","volume":"66","author":"Yokota","year":"2009","journal-title":"Arch Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.expneurol.2008.07.022","article-title":"DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation.","volume":"214","author":"Bosnakovski","year":"2008","journal-title":"Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1038\/emboj.2008.201","article-title":"An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies.","volume":"27","author":"Bosnakovski","year":"2008","journal-title":"EMBO J"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jmg.2008.060541","article-title":"Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.","volume":"45","author":"Davidovic","year":"2008","journal-title":"J Med Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mrfmmm.2008.07.011","article-title":"Epigenetic mechanisms of facioscapulohumeral muscular dystrophy.","volume":"647","author":"de Greef","year":"2008","journal-title":"Mutat Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mrfmmm.2008.07.011","article-title":"Epigenetic mechanisms of facioscapulohumeral muscular dystrophy [Review].","volume":"647","author":"de Greef","year":"2008","journal-title":"Mutat Res-Fundam Mol Mech Mutagen"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"18157","DOI":"10.1073\/pnas.0708659104","article-title":"DUX4, a candidate gene of facioscapulohumeral muscular dystropy encodes a transcriptional activator of PITX1.","volume":"104","author":"Dixit","year":"2007","journal-title":"Proc Nat Acad Sci U S A"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nmd.2007.12.005","article-title":"Novel mitochondrial tRNA(Leu(CUN)) transition and D4Z4 partial deletion in a patient with a facioscapulohumeral phenotype.","volume":"18","author":"Filosto","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijcard.2007.12.041","article-title":"Atrial fibrillation\/flutter in myopathies [Review].","volume":"128","author":"Finsterer","year":"2008","journal-title":"Int J Cardiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/dvdy.21830","article-title":"Muscular dystrophy candidate gene FRG1 is critical for muscle development.","volume":"238","author":"Hanel","year":"2009","journal-title":"Dev Dyn"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1007\/s10072-008-0949-7","article-title":"Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.","volume":"29","author":"Kalkman","year":"2008","journal-title":"Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.nmd.2009.02.009","article-title":"Quantiative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.","volume":"19","author":"Kan","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3346\/jkms.2008.23.6.959","article-title":"Clinical and Genetic Analysis of Korean Patients with Facioscapulohumeral Muscular Dystrophy.","volume":"23","author":"Ki","year":"2008","journal-title":"J Korean Med Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.nmd.2008.03.011","article-title":"Phenotype of combined Duchenne and facioscapulohumeral muscular dystrophy.","volume":"18","author":"Korngut","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/521986","article-title":"Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy.","volume":"81","author":"Lemmers","year":"2007","journal-title":"Am J Hum Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1212\/01.wnl.0000251269.31442.d9","article-title":"Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.","volume":"68","author":"Osborne","year":"2007","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"e1000394","DOI":"10.1371\/journal.pgen.1000394","article-title":"The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy.","volume":"5","author":"Ottaviani","year":"2009","journal-title":"PLoS Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.nmd.2008.06.387","article-title":"Beckers muscular dystrophy aggravating facioscapulohumeral muscular dystrophy - double trouble as an explanation for an atypical phenotype.","volume":"18","author":"Rudnik-Schoneborn","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","first-page":"745","article-title":"Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophy.","volume":"126","author":"Sheth","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"-20210206","first-page":"746","article-title":"Detection of facial hypotonia and diagnosis of facioscapulohumeral dystrophy - Reply.","volume":"126","author":"Shields","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.nmd.2008.07.005","article-title":"The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).","volume":"18","author":"Skalsky","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00455-007-9141-0","article-title":"Facioscapulohumeral Muscular Dystrophy: A Radiologic and Manometric Study of the Pharynx and Esophagus.","volume":"23","author":"Stubgen","year":"2008","journal-title":"Dysphagia"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.nurt.2008.07.005","article-title":"Facioscapulohumeral muscular dystrophy [Review].","volume":"5","author":"Tawil","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1468-1331.2008.02314.x","article-title":"Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions.","volume":"15","author":"Trevisan","year":"2008","journal-title":"Eur J Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/II trial of MYO-029 in adult subjects with muscular dystrophy.","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1242\/dmm.002261","article-title":"FSHD region 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.","volume":"2","author":"Wuebbles","year":"2009","journal-title":"Dis Model Mech"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/mus.21100","article-title":"Cognitive impairment and cerebellar atrophy in typical onset 4q35 fascioscapulohumeral dystrophy.","volume":"38","author":"Zouvelou","year":"2008","journal-title":"Muscle Nerve"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.apmr.2008.09.001","article-title":"Pain in Myotonic Muscular Dystrophy, Type 1.","volume":"89","author":"Carter","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijcard.2007.12.041","article-title":"Atrial fibrillation\/flutter in myopathies [Review].","volume":"128","author":"Finsterer","year":"2008","journal-title":"Int J Cardiol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.apmr.2007.10.049","article-title":"Predictors of disrupted social participation in myotonic dystrophy type 1.","volume":"89","author":"Gagnon","year":"2008","journal-title":"Arch Phys Med Rehabil"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.","volume":"358","author":"Groh","year":"2008","journal-title":"N Engl J Med"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.cellsig.2008.05.005","article-title":"Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1 [Review].","volume":"20","author":"Kaliman","year":"2008","journal-title":"Cell Signal"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1007\/s10072-008-0949-7","article-title":"Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue.","volume":"29","author":"Kalkman","year":"2008","journal-title":"Neurol Sci"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jbspin.2007.11.008","article-title":"Camptocormia and dropped head syndrome as a clinic picture of myotonic myopathy.","volume":"75","author":"Kocaaga","year":"2008","journal-title":"Joint Bone Spine"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/NEN.0b013e318180ec64","article-title":"Myotonic dystrophy transgenic mice exhibit pathologic abnormalities in diaphragm neuromuscular junctions and phrenic nerves.","volume":"67","author":"Panaite","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000324257.35759.40","article-title":"Dehydroepiandrosterone for myotonic dystrophy type 1.","volume":"71","author":"Penisson-Besnier","year":"2008","journal-title":"Neurology"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.dnarep.2008.03.014","article-title":"Mutagenic roles of DNA repair proteins in antibody diversity and disease-associated trinucleotide repeat instability [Review].","volume":"7","author":"Slean","year":"2008","journal-title":"DNA Repair"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1101\/gr.070409.107","article-title":"The biological effects of simple tandem repeats: Lessons from the repeat expansion diseases [Review].","volume":"18","author":"Usdin","year":"2008","journal-title":"Genome Res"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nmd.2008.05.003","article-title":"Caveolinopathy: new mutations and additional symptoms.","volume":"18","author":"Aboumousa","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jpedsurg.2008.08.066","article-title":"Indication for pediatric muscle biopsy determines usefulness.","volume":"43","author":"Jamshidi","year":"2008","journal-title":"J Pediatr Surg"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1750-1172-3-26","article-title":"Centronuclear (myotubular) myopathy.","volume":"3","author":"Jungbluth","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000170095","article-title":"Utility of Fetal Muscle Biopsy for Diagnosis of Nemaline Myopathy.","volume":"24","author":"Kasperski","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"-20210206","first-page":"568","article-title":"McArdle disease: what do neurologists need to know Nat Clin Pract N","volume":"4","author":"Lucia","year":"2008","journal-title":"eurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.nurt.2008.08.005","article-title":"Muscular dystrophies due to glycosylation defects.","volume":"5","author":"Muntoni","year":"2008","journal-title":"Neurotherapeutics"},{"key":"-20210206","first-page":"433","article-title":"Whats new in congenital myopathies Neuromuscul D","volume":"18","author":"North","year":"2008","journal-title":"isord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-0004.2008.01068.x","article-title":"LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients.","volume":"74","author":"Oliveira","year":"2008","journal-title":"Clin Genet"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2009.01.054","article-title":"VMA21 deficiency causes an autophagic myopathy by compromising V-ATPase activity and lysosomal acidification.","volume":"137","author":"Ramachandran","year":"2009","journal-title":"Cell"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2009.01.002","article-title":"Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.","volume":"19","author":"Schoser","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/WCO.0b013e32830a752b","article-title":"Myofibrillar myopathies.","volume":"21","author":"Selcen","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/WCO.0b013e32830f93c7","article-title":"Congenital myopathies.","volume":"21","author":"Sewry","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"-20210206","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.nmd.2009.01.009","article-title":"Valosin-containing protein disease: inclusion body myopathy with Pagets disease of the bone and fronto-temporal dementia.","volume":"19","author":"Weihl","year":"2009","journal-title":"Neuromuscul Disord"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e3283313b14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T18:53:38Z","timestamp":1633892018000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-200910000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":436,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3283313b14","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}